{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T04:11:51Z","timestamp":1747368711824,"version":"3.40.5"},"reference-count":6,"publisher":"American Academy of Insurance Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Insur Med"],"published-print":{"date-parts":[[2023]]},"abstract":"NAFLD (non-alcoholic fatty liver disease) and NASH (non-alcoholic steatohepatitis) are time-honored acronyms, with widely popular acceptance. Experts now recommend discarding them in favor of MASLD for \u201cmetabolic dysfunction-associated steatotic liver disease\u201d and MASH for \u201cmetabolic dysfunction-associated steatohepatitis.\u201d The reasons for this change are explored and an argument about why the change is confusing, is advanced. Should these acronyms become clinically popular, risk assessment manuals will require updates.<\/jats:p>","DOI":"10.17849\/insm-50-2-147-149.1","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T17:02:49Z","timestamp":1708016569000},"page":"147-149","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic Muddle. MASLD and MASH on the Horizon"],"prefix":"10.17849","volume":"50","author":[{"given":"Timothy","family":"Meagher","sequence":"first","affiliation":[{"name":"Address of Correspondent: Munich Re, 1000 Rue de la Gaucheti\u00e8re Ouest, 20e \u00e9tage, Montr\u00e9al Qu\u00e9bec, H3B 4W5; 514-392-5069; tmeagher@munichre.ca"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7324","reference":[{"key":"i0743-6661-50-2-147-ref01","series-title":"Mayo Clinic Proceedings","first-page":"434","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","unstructured":"Ludwig\n J,\n \n \n Viggiano\n TR,\n \n \n McGill\n DB,\n \n et al.\n \n Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.\nMayo Clinic Proceedings.\n1980;\n55:\n434-\n438.\nPMID: 7382552."},{"key":"i0743-6661-50-2-147-ref02","series-title":"J Hepatol","first-page":"202","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","unstructured":"Eslam\n M,\n \n \n Newsome\n PN,\n \n \n Sarin\n SK,\n \n et al.\n \n A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement.\nJ Hepatol.\n2020;\n73:\n202-\n209.\ndoi:10.1016\/j.jhep.2020.03.039"},{"key":"i0743-6661-50-2-147-ref03","series-title":"Gastroenterology","first-page":"1999","article-title":"MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease","volume":"158","author":"Eslam","year":"2020","unstructured":"Eslam\n A,\n \n \n Sanyal\n J,\n \n \n George\n J,\n \n et al.\n \n MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.\nGastroenterology.\n2020;\n158:\n1999-\n2014.\nhttps:\/\/doi.org\/10.1053\/j.gastro.2019.11.312."},{"key":"i0743-6661-50-2-147-ref04","series-title":"Hepatol","article-title":"A multi-society Delphi consensus statement on new fatty liver disease nomenclature","author":"Rinella","year":"2023","unstructured":"Rinella\n ME,\n \n \n Lazarus\n JV,\n \n \n Ratziu\n V,\n \n et al.\n \n A multi-society Delphi consensus statement on new fatty liver disease nomenclature\n [published online ahead of print, 2023 Jun 24].\nHepatol.\n2023;\n10.1097\/HEP.0000000000000520.\ndoi:10.1097\/HEP.0000000000000520"},{"key":"i0743-6661-50-2-147-ref05","series-title":"Am J Clin Nutri","first-page":"1237","article-title":"The metabolic syndrome: is this diagnosis necessary","volume":"83","author":"Reaven","year":"2006","unstructured":"Reaven\n G.\n \n \n The metabolic syndrome: is this diagnosis necessary?\nAm J Clin Nutri.\n2006;\n83:\n1237-\n1247.\nhttps:\/\/doi.org\/10.1093\/ajcn\/83.6.1237"},{"key":"i0743-6661-50-2-147-ref06","series-title":"Diabetologia","first-page":"1684","article-title":"The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"48","author":"Kahn","year":"2005","unstructured":"Kahn\n R,\n \n \n Buse\n J,\n \n \n Ferrannini,\n \n \n et al.\n The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.\nDiabetologia.\n2005;\n48:\n1684-\n1699.\ndoi:10.1007\/s00125-005-1876-2"}],"container-title":["Journal of Insurance Medicine"],"original-title":[],"link":[{"URL":"https:\/\/jim.kglmeridian.com\/view\/journals\/insm\/50\/2\/article-p147.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/jim\/article-pdf\/50\/2\/147\/3330478\/i0743-6661-50-2-147.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jim.kglmeridian.com\/downloadpdf\/journals\/insm\/50\/2\/article-p147.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jim.kglmeridian.com\/downloadpdf\/journals\/insm\/50\/2\/article-p147.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:39:35Z","timestamp":1747355975000},"score":1,"resource":{"primary":{"URL":"https:\/\/jim.kglmeridian.com\/view\/journals\/insm\/50\/2\/article-p147.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":6,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.17849\/insm-50-2-147-149.1","relation":{},"ISSN":["0743-6661"],"issn-type":[{"type":"print","value":"0743-6661"}],"subject":[],"published":{"date-parts":[[2023]]}}}